DavidHeadMD

Pathology • Nashville, TN

Hematopathology, Anatomic Pathology, Clinical Pathology

Professor, Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine

Join to view full profile

Dr. Head is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Head's full profile

Already have an account?

Office
3601 21st Ave S
Nashville, TN 37232
Phone+1 615-322-3000

Fax+1 615-936-0605

Education & Training

Fitzsimons Army Medical CenterResidency, Pathology-Anatomic and Clinical, 1969 - 1973
University of Texas Medical Branch School of MedicineClass of 1968

Certifications & Licensure

TN State Medical License 1989 - 2025
TX State Medical License 1968 - 2017
UT State Medical License 1983 - 1990
American Board of Pathology Anatomic Pathology & Clinical Pathology
American Board of Pathology Hematology

Publications & Presentations

PubMed

Multiplex imaging reveals spatially resolved DNA-damage response neighborhoods in TP53-mutated myelodysplastic neoplasms.
Tony Yeung, Yi Zhang, Bridget Kennedy, Cara Walsh, Tanzy Love
The Journal of Pathology. 2024-07-01
5 citations
Primary central nervous system erythroid sarcoma with NFIA-CBFA2T3 translocation: A rare but distinct clinicopathologic entity.
Yevgeniy Linnik, Devang Pastakia, Ian Dryden, David R. Head, Emily F. Mason
American Journal of Hematology. 2020-08-17
8 citations
Pathologic Features of Down Syndrome Myelodysplastic Syndrome and Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML0431
Kelley Mast, Jeffrey W. Taub, Todd A. Alonzo, Alan S. Gamis, Claudio A. Mosse
Archives of Pathology & Laboratory Medicine. 2020-04-01

Press Mentions

Argus Research Initiates Equity Research Report Coverage on XORTX Therapeutics Inc. (Nasdaq: XRTX)November 15th, 2021
Summit Therapeutics to Participate in Panel Sessions at the World Antimicrobial Resistance CongressNovember 6th, 2019
Podcast: What’s Missing from Your Teacher Engagement StrategyAugust 27th, 2019
Join now to see all